PURR Share Price Performance
US$4.56
0.66 (16.92%)
Price US$4.56
Share Pricen/a
No recently updated narratives available.
Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company was incorporated in 2025 and is based in New York, New York.